Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ACP3 | P15309 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | IDO2 | Q6ZQW0 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7666179 | 0.83 | CYP1A2 (0.43) | SMN1; SMN2ALDH1A1LMNATSHR | |
| SCHEMBL11621991 | 0.78 | ACP3 (0.38) | ALDH1A1HTTACP3LMNATSHR | |
| SCHEMBL477602 | 0.77 | ACP3 (0.53) | SMN1; SMN2ALDH1A1ACP3LMNATSHR | |
| SCHEMBL477580 | 0.77 | ACP3 (0.53) | SMN1; SMN2ALDH1A1ACP3LMNATSHR | |
| SCHEMBL29609159 | 0.77 | ACP3 (0.53) | SMN1; SMN2ALDH1A1ACP3LMNATSHR | |
| SCHEMBL29105288 | 0.77 | KCNQ2 (0.46) | SMN1; SMN2ALDH1A1LMNATSHRHPGD | |
| SCHEMBL477355 | 0.77 | IDO1 (0.54) | ALDH1A1ACP3LMNATSHRCACNA2D1 | |
| SCHEMBL4182232 | 0.77 | LMNA (0.44) | SMN1; SMN2ALDH1A1HTTLMNAHPGD | |
| SCHEMBL5623441 | 0.76 | TSHR (0.43) | HTTACP3LMNATSHRCACNA2D1 | |
| SCHEMBL6578256 | 0.74 | MEN1 (0.50) | SMN1; SMN2LMNATSHRHPGDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1582524-B1 | Method of preparing organomagnesium compounds | UNIV MUENCHEN L MAXIMILIANS (DE) | 2008-08-13 | — | — | EP | disclosed |
| US-7387751-B2 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2008-06-17 | — | — | US | disclosed |
| US-7387751-B2 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2008-06-17 | — | — | US | disclosed |
| US-7384580-B2 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2008-06-10 | — | — | US | disclosed |
| US-7384580-B2 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2008-06-10 | — | — | US | disclosed |
| US-20070194468-A1 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20070194468-A1 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2007-08-23 | — | — | US | disclosed |
| EP-0801048-A1 | Process for producing benzhydrols | K I CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070194468-A1 | Method of preparing organomagnesium compounds | SCLY, LIG3, LIG4 | SMN1; SMN2 4369/4885ALDH1A1 1914/4885HTT 3589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.